Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Cash: 2022-2024

Historic Change in Cash for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$86.5 million.

  • Lexeo Therapeutics' Change in Cash rose 611.58% to $86.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $44.1 million, marking a year-over-year change of. This contributed to the annual value of -$86.5 million for FY2024, which is 295.90% down from last year.
  • Latest data reveals that Lexeo Therapeutics reported Change in Cash of -$86.5 million as of FY2024, which was down 295.90% from $44.1 million recorded in FY2023.
  • Lexeo Therapeutics' 5-year Change in Cash high stood at $44.1 million for FY2023, and its period low was -$86.5 million during FY2024.
  • Over the past 3 years, Lexeo Therapeutics' median Change in Cash value was -$55.3 million (recorded in 2022), while the average stood at -$32.5 million.
  • In the last 5 years, Lexeo Therapeutics' Change in Cash soared by 179.84% in 2023 and then plummeted by 295.90% in 2024.
  • Over the past 3 years, Lexeo Therapeutics' Change in Cash (Yearly) stood at -$55.3 million in 2022, then skyrocketed by 179.84% to $44.1 million in 2023, then crashed by 295.90% to -$86.5 million in 2024.